Targeted Therapy of AML1/ETO-Positive AML Cells in Experimental Model

被引：0
|
作者：
Zapotocky, Michal [1 ]
Starkova, Julia [1 ]
Mejstrikova, Ester [1 ]
Smetana, Karel [2 ]
Trka, Jan [1 ]
机构：
[1] Charles Univ Prague, Sch Med 2, CLIP, Prague, Czech Republic
[2] Charles Univ Prague, Sch Med 1, Inst Hematol & Blood Transfus, Prague, Czech Republic
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1153 / 1153
页数：1
相关论文
共 50 条
  • [1] Treatment with valproic acid restores differentiation in AML1/ETO-positive leukaemic cells
    Zapotocky, M.
    Starkova, J.
    Mejstrikova, E.
    Smetana, K.
    Trka, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 42 - 42
  • [2] Treatment with valproic acid restores differentiation in AML1/ETO-positive leukaemic cells
    Zapotocky, Michal
    Starkova, Julia
    Mejstrikova, Ester
    Smetana, Karel
    Trka, Jan
    BLOOD, 2007, 110 (11) : 141B - 141B
  • [3] Valproic acid triggers differentiation and apoptosis in AML1/ETO-positive leukemic cells specifically
    Zapotocky, Michal
    Mejstrikova, Ester
    Smetana, Karel
    Stary, Jan
    Trka, Jan
    Starkova, Julia
    CANCER LETTERS, 2012, 319 (02) : 144 - 153
  • [4] Identification of Epigenetic Modifiers Essential for Growth and Survival of AML1/ETO-Positive Leukemia
    Afonso, Jesus Duque
    Pia, Veratti
    Rehman, Usama-Ur
    Herzog, Heike
    Mitschke, Jan
    Greve, Gabriele
    Eble, Julian
    Berberich, Bettina
    Thomas, Johanna
    Pantic, Milena
    Waterhouse, Miguel
    Gentile, Gaia
    Heidenreich, Olaf
    Miething, Cornelius
    Luebbert, Michael
    BLOOD, 2023, 142
  • [5] The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia
    Nagai, Surnimasa
    Ichikawa, Motoshi
    Takahashi, Tsuyoshi
    Sato, Hiroyuki
    Yokota, Hiromitsu
    Shima, Kurni
    Izutsu, Koji
    Hangaishi, Akira
    Kanda, Yoshinobu
    Motokura, Toru
    Chiba, Shigeru
    Yatomi, Yutaka
    Kurokawa, Mineo
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (11) : 1747 - 1752
  • [6] Identification of epigenetic modifiers essential for growth and survival of AML1/ETO-positive leukemia
    Duque-Afonso, Jesus
    Veratti, Pia
    Rehman, Usama-Ur
    Herzog, Heike
    Mitschke, Jan
    Greve, Gabriele
    Eble, Julian
    Berberich, Bettina
    Thomas, Johanna
    Pantic, Milena
    Waterhouse, Miguel
    Gentile, Gaia
    Heidenreich, Olaf
    Miething, Cornelius
    Luebbert, Michael
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (11) : 2068 - 2079
  • [7] Re-Expression of the AML1/ETO Target Gene LAT2/NTAL/LAB Results In Direct Interference with Myeloid Differentiation In AML1/ETO-Positive Cells
    Duque-Afonso, Jesus
    Essig, Aitomi
    Solari, Leticia M.
    Berg, Tobias
    Pahl, Heike L.
    Luebbert, Michael
    BLOOD, 2010, 116 (21) : 1027 - 1028
  • [8] THE MECHANISM UNDERLYING BIOLOGICAL EFFECT OF VALPROIC ACID IN TARGETED THERAPY OF AML1/ETO POSITIVE CELLS
    Zapotocky, M.
    Starkova, J.
    Mejstrikova, E.
    Trka, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 687 - 687
  • [9] Comparision of the Clinical and Prognostic Characteristic in Adult and Pediatric AML1/ETO-Positive Acute Myeloid Leukemia
    Yu, Guopan
    Zhou, Jiaheng
    Zhou, Jinchan
    Qiu, Jiale
    Yin, Zhao
    Yin, Changxin
    Xu, Dan
    Jiang, Xuejie
    Liu, Qifa
    Meng, Fanyi
    BLOOD, 2018, 132
  • [10] Targeting AML1/ETO-histone deacetylase repressor complex: A novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells
    Liu, Shujun
    Klisovic, Rebecca B.
    Vukosavljevic, Tamara
    Yu, Jianhua
    Paschka, Peter
    Huynh, Lenguyen
    Pang, Jiuxia
    Neviani, Paolo
    Liu, Zhongfa
    Blum, William
    Chan, Kenneth K.
    Perrotti, Danilo
    Marcucci, Guido
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (03): : 953 - 960
12345